Nippon Shinyaku Co.,Ltd. Logo

Nippon Shinyaku Co.,Ltd.

Develops pharmaceuticals and functional foods to improve healthcare and wellbeing.

4516 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
京都市南区吉祥院西ノ庄門口町14番地
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Nippon Shinyaku Co., Ltd. is a research and development-oriented company engaged in the manufacturing and commercialization of pharmaceuticals and functional foods. The company's core business is its Pharmaceuticals division, which develops and sells a range of prescribed drugs, including specialty and generic medications, with a focus on therapeutic areas such as urinary, neurological, respiratory, and circulatory disorders. The Functional Foods division leverages the company's pharmaceutical expertise to produce and market high-quality health food products. Nippon Shinyaku is committed to supplying original, high-quality products to contribute to the healthcare sector and improve wellbeing.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Nippon Shinyaku Co.,Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-04 06:16
Regulatory News Service
臨時報告書
Japanese 27.7 KB
2025-06-24 06:23
Regulatory News Service
確認書
Japanese 8.6 KB
2025-06-24 06:22
Regulatory News Service
内部統制報告書-第162期(2024/04/01-2025/03/31)
Japanese 26.1 KB
2025-06-24 06:18
Annual Report
有価証券報告書-第162期(2024/04/01-2025/03/31)
Japanese 1.6 MB
2024-11-14 02:12
Regulatory News Service
確認書
Japanese 8.6 KB
2024-11-14 02:11
Interim Report
半期報告書-第162期(2024/04/01-2025/03/31)
Japanese 233.5 KB
2024-07-01 04:04
Regulatory News Service
臨時報告書
Japanese 29.3 KB
2024-06-28 04:07
Regulatory News Service
内部統制報告書-第161期(2023/04/01-2024/03/31)
Japanese 23.3 KB
2024-06-28 04:01
Regulatory News Service
確認書
Japanese 8.6 KB
2024-06-28 03:58
Annual Report
有価証券報告書-第161期(2023/04/01-2024/03/31)
Japanese 1.5 MB
2024-02-14 02:06
Regulatory News Service
確認書
Japanese 8.6 KB
2024-02-14 02:05
Quarterly Report
四半期報告書-第161期第3四半期(2023/10/01-2023/12/31)
Japanese 244.8 KB
2023-11-14 01:59
Regulatory News Service
確認書
Japanese 8.6 KB
2023-11-14 01:59
Quarterly Report
四半期報告書-第161期第2四半期(2023/07/01-2023/09/30)
Japanese 262.0 KB
2023-08-14 03:04
Regulatory News Service
確認書
Japanese 8.6 KB

Automate Your Workflow. Get a real-time feed of all Nippon Shinyaku Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Nippon Shinyaku Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
H. Lundbeck A Logo
Develops and commercializes innovative therapeutics for brain diseases globally.
Denmark HLUN
Global provider of medical aesthetic solutions like botulinum toxin and HA fillers.
South Korea 145020
Human Stem Cells Institute PJSC Logo
A biotech investor developing gene therapy, regenerative medicine, and genetic services.
Russian Federation ISKJ
HUMASIS CO., LTD. Logo
Develops & manufactures rapid in-vitro diagnostic test kits & instruments for global POCT markets.
South Korea 205470
Humedix Co., Ltd. Logo
Develops hyaluronic acid-based pharma, aesthetics, medical devices, and offers CMO services.
South Korea 200670
HUONS CO., LTD. Logo
Global healthcare company providing pharmaceuticals, medical devices, and wellness products.
South Korea 243070
Huons Global Co., Ltd. Logo
Develops pharmaceuticals, medical devices, cosmetics, and health foods for the global market.
South Korea 084110
Hong Kong N/A
HWAIL PHARM. CO., LTD Logo
Develops and manufactures APIs, finished drugs, and functional ingredients for healthcare.
South Korea 061250
Hyloris Pharmaceuticals SA Logo
A biopharma company optimizing existing drugs for unmet needs via abbreviated pathways.
Belgium HYL

Talk to a Data Expert

Have a question? We'll get back to you promptly.